Vector-borne diseases (VBDs) represent a significant challenge to public health in India. The country's vast geographical diversity and climatic variations create an environment conducive to the spread of various vectors, leading to a high disease burden.
India is currently grappling with a multitude of VBDs including malaria, dengue, chikungunya, and Japanese encephalitis. Malaria alone accounts for a significant portion of the disease burden, with the World Health Organisation estimating around 6.7 million cases in 2018. Additionally, the increasing incidence of dengue and chikungunya pose a substantial threat to public health.
The fight against VBDs in India is fraught with challenges. These include the lack of effective vector control strategies, inadequate healthcare infrastructure, and gaps in disease surveillance. Additionally, the effects of climate change, urbanisation, and population mobility further exacerbate the situation.
Effective control of VBDs necessitates a multi-pronged approach. This includes strengthening surveillance systems, improving diagnostic capabilities, and implementing effective vector control strategies. In addition, increasing community awareness and participation, and fostering intersectoral coordination are crucial. The recent launch of the National Vector Borne Disease Control Programme (NVBDCP) is a step in the right direction, aiming to reduce the morbidity and mortality associated with VBDs.
Vector-borne diseases pose a significant public health challenge in India. While the situation is daunting, a concerted effort involving the government, healthcare professionals, and the community can make a significant difference. By strengthening healthcare infrastructure, improving surveillance, and implementing effective control strategies, India can turn the tide against these diseases. The battle is far from over, but with a comprehensive and coordinated approach, victory is within reach.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation